Allogene Therapeutics Inc
(ALLO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Operating Expenses | 202,008 | 192,842 | 0 | 0 |
| Operating Income | -202,008 | -192,842 | N/A | N/A |
| Interest Expense | 0 | 3,358 | 0 | 0 |
| Other Income | 17,083 | -15,422 | 0 | 0 |
| Pre-tax Income | -184,925 | -211,622 | 0 | 0 |
| Income Tax | -331 | -117 | 0 | N/A |
| Net Income Continuous | -184,594 | -211,505 | N/A | N/A |
| Net Income | $-184,594 | $-211,505 | $0 | $N/A |
| EPS Basic Total Ops | -1.83 | -7.31 | N/A | N/A |
| EPS Basic Continuous Ops | -1.83 | -7.31 | N/A | N/A |
| EPS Diluted Total Ops | -1.83 | -7.31 | N/A | N/A |
| EPS Diluted Continuous Ops | -1.83 | -7.31 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -1.83 | N/A | N/A | N/A |
| EBITDA(a) | $-200,577 | $-192,378 | $N/A | $N/A |